CD56-negative extranodal nasal type of natural killerT-cell lymphoma with extranasal skin involvement

Leukemia and Lymphoma

Volumn 50, Issue 10, 2009, Pages 1715-1717

  Lan, Mo Xiang ^a,b   Zhen, Zhou Xiang ^a   Ming, Wei Hai ^a  

^a Department of Pathology ^*  (China)

^b Guangxi People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ADULT; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; DISEASE DURATION; DISSEMINATED INTRAVASCULAR CLOTTING; EYE BIOPSY; EYE SWELLING; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABORATORY TEST; LETTER; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NK T CELL LYMPHOMA; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SKIN; SKIN BIOPSY; SKIN DEFECT; SKIN NODULE; SKIN ULCER; SUBCUTANEOUS NODULE; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; WEIGHT REDUCTION;

ANTIGENS, CD56; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CONNECTIVE TISSUE DISEASES; CYCLOPHOSPHAMIDE; DIAGNOSTIC ERRORS; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; EYELID NEOPLASMS; FATAL OUTCOME; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL, CUTANEOUS; MALE; NOSE; PREDNISOLONE; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTE SUBSETS; VINCRISTINE; YOUNG ADULT;

EID: 70350769294     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190903191866     Document Type: Letter

References (11)

1. Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh SC. Extranodal NK/T cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NK, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4 th ed. Lyon: IARC press; 2008. pp 285-288.
2. Ng SB, Lai KW, Murugaya S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: A clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004;17:1097-1107.
3. Katsaounis P, Alexopoulou A, Dourakis SP, et al. An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features. Int J Hematol 2008;88:202-205.
4. Chang BH, Stork L, Fan G. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type. Pediatr Dev Pathol 2008;11:50-54.
5. Stokkermans-Dubois J, Jouary T, Vergier B, Delaunay MM, Taieb A. A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature. Dermatology 2006;213:345-349.
6. Choi YL, Park JH, Namkung JH, et al. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups -a retrospective study of 18 patients. Br J Dermatol 2009;160:333-337.
7. Xiang-Lan M, Zu-Lan S, He Dan, Bi-Hong S, Pang-Ya Q, Han-Liang L. Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma. Transl Res 2008;151:303-308.
8. Ruskova A, Thula R, Chan G. Aggressive natural killer-cell leukemia: Report of five cases and review of the literature. Leuk Lymphoma 2004;45:2427-2438.
9. Yamaguchi M, Suzuki R, Kwong YL, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016-1020.
10. Bang SM, Kim YK, Park YH, et al. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma. Lymphoma 2005;46:1599-1604.
11. Murashige N, Kami M, Kishi Y, et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005;130:561-567.